Class Action - Statins Increases Heart Disease By 10% In Women
"...women who are taking Lipitor without heart disease actually developed 10 percent more heart attacks than women treated with a placebo."
I repeatedly get questions on what one should do if they are having side effects and/or have been told by there MD's to lower their cholesterol. The conditioning is so strong that most repeatedly over look the damaging evidence of the said drugs and continue to feel they are doomed if their cholesterol is even slightly high. Hopefully this will settle the question once and for all. The side effects are a sign of toxicity of the drugs and hence should be stopped. Cholesterol in the main is not the cause of heart disease but can be a symptom of heart disease and is often protective. Lowering it in many cases, as shown here, can be more detrimental the leaving it alone!
For those struggling with issues on statins (cholesterol lowering drugs); here is a clear cut example on why these drugs are not the answer and an opportunity to participate in the class action for those who feel duped which have been!
"Consumers have filed the first-of-its-kind, nationwide class action lawsuit against Pfizer, maker of the popular cholesterol-lowering, statin-type drug Lipitor. The lawsuit alleges that Pfizer engaged in a massive campaign to convince both doctors and patients that Lipitor is a beneficial treatment for nearly everyone with elevated cholesterol, even though no studies have shown it to be effective for those over 65, and for women at any age who do not already have heart disease or diabetes. In fact, the ASCOT study, the largest clinical trial on the effectiveness of statin therapy in women, found that women at increased risk of developing heart disease who took Lipitor developed 10 percent more heart attacks than the women who took the placebo. The proposed class action seeks to represent women who have taken Lipitor and who have no history of heart disease or diabetes: people aged 65 and over who have taken Lipitor and who have no history of heart disease or diabetes; and third-party payers such as insurance companies, union health and welfare funds, self-insured employers and others who paid for Lipitor for patients in either of these two groups. The law suit was filed in US District Court in Boston by Steve Berman, managing partner of Hagens Berman Sobol Shapiro on behalf of several individuals. Health Care of All and the Teamsters. For further information see www.hbsslaw.com"
Extracted from: Wise Traditions Journal Volume 6 Number Three Fall 2005
Date Filed: September 28, 2005
Court: U.S. District Court
Ticker Symbol: PFE
Hagens Berman Sobol Shapiro has filed a nationwide class-action lawsuit on behalf of individual consumers, a number of labor unions and senior advocacy organizations who purchased the drug LipitorŪ. The suit claims that the drug's manufacturer, Pfizer, Inc. (NYSE: PFE), misled consumers about the benefits of Lipitor through deceptive marketing and advertising activities.
Lipitor is in the class of cholesterol-lowering drugs called statins and is the best-selling drug in the world. In 2004 Lipitor sales reached more than $10 billion. It is estimated that out of the 2004 sales, billions came from patients who do not benefit from the drug.
According to the complaint, Pfizer launched a massive campaign to convince the public that Lipitor is a beneficial treatment for nearly everyone with elevated cholesterol, even though no studies have shown it to be effective for women and those over 65 years of age who do not already have heart disease or diabetes. In fact, there is evidence that women who are taking Lipitor without heart disease actually developed 10 percent more heart attacks than women treated with a placebo.
The lawsuit alleges that Pfizer violated state consumer protection laws against deceptive advertising and seeks to represent women under 65 who have taken Lipitor and who have no history of heart disease or diabetes; people aged 65 and over who have taken Lipitor and who have no history of heart disease or diabetes; and third party payers such as insurance companies, union health and welfare funds, self-insured employers and others, who paid for Lipitor for patients in either of these two groups.
For more information, read the complaint here.
For additional information, please visit www.lipitor-classaction.com, a Web site dedicated to raising awareness of this issue.
posted by Chris Gupta on Monday May 1 2006
updated on Friday June 9 2006
URL of this article:
Drinking Water Fluoridation is Genotoxic & Teratogenic
This paper by Prof. Joe Cummins is a very important 5 minute delegation made to London Ontario Canada "Civic Works Committee" public participation meeting on January 25, 2012 on fluoride*. While a bit technical it is short and easy to grasp. A must read as it goes to the heart of the matter regarding the well established toxicity of fluoride which is well in all scientific circles even before water... [read more]
February 06, 2012 - Chris Gupta
Democracy At Work? - PPM On Fluoride
Here is a commentary on the recent (Jan, 25th, 2011) Public Participation Meeting (PPM) on Fluoride in the City of London, Ontario. The meeting started with a strong pro fluoride stance form the City engineer. His lack of knowledge on chemistry of the toxic wastes used to fluoridate water could embarrass even a high school student never mind his own profession. He blatantly violated his "duty to public welfare" as... [read more]
January 29, 2012 - Chris Gupta
"Evidence Be Damned...Patient Outcome Is Irrelevant" - From Helke
Further to The Future of Complementary/Integrative Medicine & Patient Choice, here is an important must read and act note from Helke Ferrie, a superb Medical Science Writer and Publisher. Now that the true colours of the well known shortcomings of allopathic medicine are being discovered en mass, the screws are being tightened by the pharmaceutical masters on their medical puppets. It seems that they are prepared to stop at nothing.... [read more]
September 16, 2011 - Chris Gupta